Results 201 to 210 of about 255,642 (262)

Impact of Endocrine Therapy for Cancer on Periodontal Health: A Systematic Review. [PDF]

Cancers (Basel)
Romano F, Franco F, Mognetti B, Berta GN.   +3 more
europepmc   +1 more source

Natural Resistance to Ovarian Hyperstimulation Syndrome in Estrildid Finches Reveals Macrophage GPR183 as a Potential Therapeutic Target

Advanced Science, EarlyView.
Ovarian macrophage depletion reverses OHSS resistance in estrildid finches and exacerbates OHSS symptoms in rats. Activating macrophage GPR183 alleviates OHSS by reducing pro‐inflammatory factors, increasing immunomodulatory molecules, remodeling CD44/SDC4‐mediated communication, and restoring immune homeostasis.
Xiaofei Yan, Yongjie Huang, Jiabao Yang, Su Ma, Songsong Liu, Xuan Huang, Juergen Brosius, Huaping Zheng, Bing Yao, Li Chen, Shanshan Lai, Cheng Deng   +11 more
wiley   +1 more source

A Rare Case of Concurrent Tropheryma Whipplei and Pneumocystis Jirovecii Pneumonia in a Patient During Endocrine Therapy for Breast Cancer. [PDF]

Infect Drug Resist
Li X, Feng Q, Yu H.
europepmc   +1 more source

Symptom Experience and Management Needs of Breast Cancer Patients Undergoing Endocrine Therapy: A Qualitative Study. [PDF]

Patient Prefer Adherence
Qin S, Wei Y, Li H, Li C.
europepmc   +1 more source

Dormancy exit correlates with CREB1 reactivation that is a potential target to overcome endocrine therapy resistance in ER⁺ breast cancer cells. [PDF]

iScience
Duan L, O'Hara KM, Maki CG.
europepmc   +1 more source

Primary endocrine therapy versus surgery plus endocrine therapy for early-stage breast cancer in older women without frailty: a cost-effectiveness and value of implementation analysis. [PDF]

Health Econ Rev
Wang Y, Chen LC, Cheung KL, Steinke D, Gavan SP.   +4 more
europepmc   +1 more source

Hepatic steatosis and fibrosis are associated with metabolic factors rather than endocrine therapy in breast cancer patients. [PDF]

Transl Gastroenterol Hepatol
Nardelli MJ, Monteiro MJSD, Cançado GGL, Cal TCMF, Lima AQR, Pontine VP, Batista MCM, Gelape FA, Vasconcelos JC, Mota LM, Theodoro R, Passos RIFA, Miranda AMC, Rezende AML, Diniz PHC, Gomes JAS, Faria LC, Couto CA.   +17 more
europepmc   +1 more source

Sexual dysfunction in Brazilian women undergoing adjuvant endocrine therapy for breast cancer: prevalence and associated factors. [PDF]

Sci Rep
Assad-Suzuki D, Laperche-Santos D, Resende H, Moura FC, Oliveira SCS, Shimada AK, Arakelian R, Galvão ALZ, de Souza BSW, Castro AG, de Andrade MCFM, Bittencourt YCRB, Magalhães MCF, de Pádua Souza C, Paiva CE, Signorini PA, Pereira DJ, Nogueira-Rodrigues A, Rosa DD, Barroso-Sousa R.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Use of Endocrine Therapy

Hematology/Oncology Clinics of North America, 1989
Endocrine therapy is still a mainstay in the treatment of metastatic breast cancer. It has been observed that about one third of women with metastatic breast cancer will respond to endocrine therapy. This response rate is surprisingly consistent for a wide variety of endocrine approaches, with a few exceptions, such as the use of corticosteroids ...
K I, Pritchard, D J, Sutherland
openaire   +2 more sources

Endocrine consequences of opioid therapy

Psychoneuroendocrinology, 2009
Gonadal hormones are known to be affected by morphine and other opioids. In this paper, we summarize data collected in recent years which clearly indicate that the opioid-induced effects on steroid hormones depend on the opioid used and in some cases on the sex of the subject. Indeed morphine is able to reduce hormones like testosterone and cortisol in
ALOISI AM, AURILIO, Caterina, BACHIOCCO V, BIASI G, FIORENZANI P, PACE, Maria Caterina, PACI V, PARI G, PASSAVANTI G, RAVAIOLI L, SINDACO G, VELLUCCI R, CECCARELLI I.   +12 more
openaire   +3 more sources